BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15901903)

  • 1. Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years.
    Lim AY; Gaffney K; Scott DG
    Rheumatology (Oxford); 2005 Aug; 44(8):1051-5. PubMed ID: 15901903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancytopenia and severe cytopenia induced by low-dose methotrexate. Eight case-reports and a review of one hundred cases from the literature (with twenty-four deaths).
    Berthelot JM; Maugars Y; Hamidou M; Chiffoleau A; Barrier J; Grolleau JY; Prost A
    Rev Rhum Engl Ed; 1995; 62(7-8):477-86. PubMed ID: 8574610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate-induced pancytopenia: a case series of 46 patients.
    Ajmani S; Preet Singh Y; Prasad S; Chowdhury A; Aggarwal A; Lawrence A; Misra R; Mishra R; Agarwal V
    Int J Rheum Dis; 2017 Jul; 20(7):846-851. PubMed ID: 28261918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancytopenia associated with low dose methotrexate therapy. A regional survey.
    al-Awadhi A; Dale P; McKendry RJ
    J Rheumatol; 1993 Jul; 20(7):1121-5. PubMed ID: 8371202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects of low dose methotrexate in rheumatoid arthritis patients.
    Gilani ST; Khan DA; Khan FA; Ahmed M
    J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancytopenia related eosinophilia in rheumatoid arthritis: a specific methotrexate phenomenon?
    Bruyn GA; Velthuysen E; Joosten P; Houtman PM
    J Rheumatol; 1995 Jul; 22(7):1373-6. PubMed ID: 7562775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy.
    Hocaoglu N; Atilla R; Onen F; Tuncok Y
    Hum Exp Toxicol; 2008 Jul; 27(7):585-9. PubMed ID: 18829735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cotton wool spots as an indicator of methotrexate-induced blood dyscrasia.
    Klemencic S
    Optometry; 2010 Apr; 81(4):177-80. PubMed ID: 20346888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis.
    Kent PD; Luthra HS; Michet C
    J Rheumatol; 2004 Sep; 31(9):1727-31. PubMed ID: 15338491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe pancytopenia in a patient taking low dose methotrexate and probenecid.
    Basin KS; Escalante A; Beardmore TD
    J Rheumatol; 1991 Apr; 18(4):609-10. PubMed ID: 2066953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis].
    Nakazaki S; Murayama T; Katoh S
    Ryumachi; 2001 Dec; 41(6):929-37. PubMed ID: 11831013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide-associated pancytopenia with or without methotrexate.
    Chan J; Sanders DC; Du L; Pillans PI
    Ann Pharmacother; 2004; 38(7-8):1206-11. PubMed ID: 15187208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic maintenance level of methotrexate in rheumatoid arthritis].
    Tahiri L; Allali F; Jroundi I; Abouqal R; Hajjaj-Hassouni N
    Sante; 2006; 16(3):167-72. PubMed ID: 17284392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions.
    Kinder AJ; Hassell AB; Brand J; Brownfield A; Grove M; Shadforth MF
    Rheumatology (Oxford); 2005 Jan; 44(1):61-6. PubMed ID: 15611303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis.
    Calvo-Romero JM
    Ann Pharmacother; 2001 Dec; 35(12):1575-7. PubMed ID: 11793624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate induced neutropenia associated with coprescription of penicillins: serious and under-reported?
    Sathi N; Ackah J; Dawson J
    Rheumatology (Oxford); 2006 Mar; 45(3):361-2; author reply 363-4. PubMed ID: 16332953
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pancytopenia related to low-dose methotrexate: study of five cases and review of the literature].
    Serraj K; Federici L; Maloisel F; Alt M; Andrès E
    Rev Med Interne; 2007 Sep; 28(9):584-8. PubMed ID: 17451848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
    Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE
    Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pancytopenia during low-dosage methotrexate treatment in patients with rheumatoid arthritis].
    Nygaard H
    Tidsskr Nor Laegeforen; 1993 Sep; 113(22):2805-7. PubMed ID: 8211900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.